Enveric Biosciences Inc — Quarterly Cash Flow (NASDAQ:ENVB) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 3.08 M5.1 M3.55 M4.36 M5.1 M Total liabilities 1.49 M1.18 M1.36 M905.88 K918.4 K Total equity 1.59 M3.92 M2.18 M3.46 M4.18 M Total liabilities & shareholders' equities 3.08 M5.1 M3.55 M4.36 M5.1 M Total debt ————— Net debt —————

News

3 Penny Stocks to Watch Now, 4/21/26 - TipRanks.com

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.01%

Trump Administration Eyes Ibogaine Research For PTSD Treatment, Stock Jumps - Psyence Biomedical (NASDAQ:

Gilgamesh Withdraws Patent Fight Against Enveric After $1.2 Billion AbbVie Deal, CEO Says Key Drug Claims Now Uncontested - Enveric Biosciences (NASDAQ:ENVB)

Enveric Biosciences stock soars after revealing new data on lead drug candidate

Enveric’s lead drug candidate activates key pathways linked to depression relief

Enveric Advances Lead Drug With New Findings On Key Brain Receptor Signals - Enveric Biosciences (NASDAQ:ENVB)

Enveric Biosciences registers $1.35 million in new shares under ATM agreement

Enveric licenses RCANN trademark portfolio to TOTEC Pharma

Enveric Biosciences closes $1.5 million registered direct offering

Enveric Biosciences raises $1.5 million in registered direct offering

Enveric Biosciences stock rises after securing patent for novel neurological treatments